TavTech is a privately-owned company, based in Israel, with a mission to continuously develop medical and aesthetic applications based on a unique jet pressure energy technology. By using scientific principles of aeronautics, we develop and deliver state-of-the-art medical and aesthetic devices and applications that are enhancing the way non-invasive, non-ablative, non-contact treatments are carried out.Our patented technology is successfully applied in aesthetic skin rejuvenation and anti-aging under the JetPeel brand, and wound management under the JetOx brand. The company's technological principle is simple, though sophisticated: TavTech proprietary liquid vitamins and skin nutrients under our JetCare brand are accelerated using pressurized air to high velocities by means of our JetPro device, and our unique and patented non-contact JetPeel handpiece that breaks the accelerated liquid into micro-droplets. This stream of micro-droplets can be used for medical applications, and for aesthetics enhancement.We are currently active in the USA, China, Japan, Europe and many other global markets, and continually aspire to further our geographic reach, as well as innovating with new products and applications.

PerfAction Technologies, a young Israeli medical device company, is the original developer of deep intradermal tissue remodeling, and pioneers new treatment applications for aesthetics and dermatology, such as Scar Tissue remodeling, Skin Thickening and Non-Surgical Facelift. PerfAction's EnerJet platform brings together the company’s proprietary Jet Volumetric Remodeling (JVR) technology, that simultaneously delivers Kinetic Energy and a Healing Compound, to create a unique micro-trauma profile and optimal spread of the compound.

A.B. Dental Devices is a leading dental implant and accessories developer and manufacturer based in Israel. It has an innovative R&D department, state of the art manufacturing facilities including 3D printing, a global sales, marketing and distribution network, dental training and education facilities, and QA and RA support functions.

Galam is an Israeli-based international company. It is a global leader in the fructose market, as well as being a major player in the fields of other natural sweeteners and starch. Galam has production facilities in Israel, Spain and Germany. It has a global sales presence through its own sales forces complemented by a distributor network.

Mabat-Up is one of Israel's largest privately owned concerns. It is a holding company which owns: Novolog, Pharm-Up (pharmaceutical logistics), Trialog (clinical trial logistics) and Care For Life (patient compliance and adherence services).

Novolog (which merged with Pharm-Up in 2011) leads the Israeli pharmaceutical distribution market exclusively working with many of the world's largest multi-national pharmaceutical companies. It's services include advanced logistics and cold chain services including clinical trial logistics, sales and marketing, home-therapy, government and regulatory relations, and IT, data management and BI. Subsidiary companies include: Trialog (clinical trials logistics) and Care For Life (home therapy services).

Pharm-Up merged with Novolog in 2011

Novartis is one of the world's leading pharmaceutical companies. Novartis OTC is the division which specializes in Over The Counter pharmaceutical products. The Israeli subsidiary, which I managed, was during this period, the 2nd largest OTC player in the local market, and the fastest growing player. Growth was driven by both organic growth and new product introductions, and came from all sales channels. Sales and profits reached record levels during this period.

P/L responsibility for a company which markets, sells and distributes a number of branded consumer products - each leaders in their respective categories. The brands are: Brita in-home water filters and Soda Club in-home beverage systems. Methods of sales include via retail and direct to consumers via an in-house call centre and direct home deliveries.

DiverseyLever, which specializes in cleaning solutions and products to the institutional and industrial market, was a fully owned subsidiary of Unilever until it was acquired by SC Johnson and became JohnsonDiversey in 2002. In 2000, I became MD of the Israeli subsidiary in order to turn it around after a long period of heavy losses. By mid-2002 the company posted an Operational Profit for the first time in many years.

Lever Israel, the fully-owned Unilever subsidiary in Israel, specialized in Home and Personal Care consumer products. During these years, sales grew by about 25% p.a. In addition to being responsible for Sales and Logistics, I also had P/L responsibility for Unilever's subsidiary in Palestine which I established in 1998.

Osem-Nestle is one of Israel's leading food companies. I was responsible for international activities including the set-up and management of manufacturing and sales operations in India and China, and sales and distribution operations in Romania and the Czech Republic.

Axiom was a "boutique" investment bank, with offices in New York and Tel Aviv. The company provided merger and acquisition, private placement and valuation services, and executed numerous transactions, including the acquisition of Abic by Teva Pharmaceuticals for $36m.